Document is current
Any future updates will be listed below
-
Authors
Sethi, Shebani https://orcid.org/0000-0001-6938-2471
Berk, Michael https://orcid.org/0000-0002-5554-6946
Andreazza, Ana Cristina https://orcid.org/0000-0002-4323-7273
Mujica-Parodi, Lilianne Rivka
Campbell, Iain https://orcid.org/0000-0001-8756-1326
Campbell, Harry
Longhitano, Calogero
Rasgon, Natalie
Volek, Jeff https://orcid.org/0000-0001-8702-0351
Calkin, Cynthia Victoria
Ford, Judith https://orcid.org/0000-0002-6500-6548
McCullumsmith, Robert
Cunnane, Stephen
Liwinski, Timur
D’Agostino, Dominic
Frye, Mark https://orcid.org/0000-0001-6997-4215
Sarnyai, Zoltan https://orcid.org/0000-0002-2380-7902
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 16 February 2026
First Online: 30 March 2026
Competing interests
: S.S. has served as a scientific advisor for Found Health and is a co-founder of Metabolic Psychiatry Labs. Z.S. is chief scientist at Ally Sciences Ltd. M.B. has served as a consultant to AstraZeneca, Otsuka Pharmaceutical, Glaxosmithkline, Janssen Cilag, Lundbeck Merck and Servier. L.R.M.-P. is a cofounder of Neuroblox. S.C. has served as an adviser to Abbott Laboratories, Cargill and holds a patent with Nestle Health Sciences. The other authors declare no competing interests.
